Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

PHASE4CompletedINTERVENTIONAL
Enrollment

417

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

November 30, 2007

Conditions
Chronic Lung Disease
Interventions
BIOLOGICAL

Lyophilized Palivizumab

Patients will receive 15 mg/kg of lyophilized palivizumab administered intramuscularly every 30 days for a total of 5 injections.

BIOLOGICAL

Liquid Palivizumab

Patients will receive 15 mg/kg of liquid palivizumab administered intramuscularly every 30 days for a total of 5 injections.

Trial Locations (54)

11230

Maimonides Pediatric Pulmonology, Brooklyn

15010

Tri-State Pediatrics, Beaver Falls

15217

Pediatric Alliance, Southwestern, Pittsburgh

15227

South Hills Pediatrics, Pittsburgh

15236

Pediatric Alliance, Southwestern, Pittsburgh

15241

Primary Physician's Research, Inc., Pittsburgh

15401

Laurel Pediatrics, Uniontown

15650

Pediatric Alliance of Latrobe, Latrobe

16125

Greenville Medical Center, Greenville

16201

CCP - Armstrong Pediatrics, Kittanning

19140

Temple Univ. Children's Medical Center, Philadelphia

22180

Advanced Pediatrics, Vienna

25202

WVU Department of Pediatrics, Charleston

27609

Capitol Pediatric And Adolescent Center, Raleigh

28352

North Carolina Children's & Adult's Clinical Research Foundation/Purcell Clinic, Laurinburg

28779

North Carolina Children's and Adult's Clinical Research Foundation, Sylva

31904

The Allergy Center at Brookstone, Columbus

35216

Clinical Research Consultants, Hoover

35235

Birmingham Pediatric Associates, Birmingham

35487

The University of Alabama School of Medicine, Tuscaloosa

37660

Holston Medical Group; Pediatrics at Meadowview Lane, Kingsport

Holston Medical Group; Pediatrics at Stone Plaza, Kingsport

38305

Jackson Clinic, Jackson

40004

Physicians to Children and Adolescents, Bardstown

41852

Michigan Institute of Medicine, Livonia

42303

Peak Medical Research LLC, Owensboro

44118

Dr. Shelly David Senders, M.D., Inc., Cleveland

45040

Northeast Cincinnati Pediatric Associates, Inc, Mason

53566

Monroe Clinic, Monroe

57201

Brown Clinic P.L.L.P./Northridge Clinic, Watertown

58103

Dakota Clinic, Ltd. / Innvois Health, Fargo

58501

Medcenter One/Q&R Clinic, Bismarck

58701

Trinity Medical Group-Health Center Medical Arts, Minot

68134

Meridian Clinical Research, Omaha

72211

All for Kids Pediatric Clinic, Little Rock

73112

Santiago Reyes, M.D., Oklahoma City

75230

Pediatric Allergy/Immunology Associates, PA, Dallas

77004

MedPro Research, Houston

77087

Pediatric Associates, Houston

77304

Sadler Clinic, Conroe

78205

Quality Assurance Research Center, San Antonio

84041

Wee Care Pediatrics, Layton

84095

Families First Pediatrics, South Jordan

84405

Bear Care Pediatrics, Ogden

84604

Utah Valley Pediatrics, Provo

91790

Doctors Medical Group, West Covina

91791

Convenience Care, West Covina

92610

Family Medical Center, Foothill Ranch

92708

Edinger Medical Group, Fountain Valley

06360

Norwich Pediatric Group, P.C., Norwich

02118

Boston University Medical Center, Boston

02724

Pediatric Association of Fall River, Fall River

01801

Woburn Pediatric Associates, Woburn

07503

St. Joseph's Childrens Hospital, Paterson

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MedImmune LLC

INDUSTRY

NCT00233064 - Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) | Biotech Hunter | Biotech Hunter